Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology and immunology therapies, announced IMULDOSA® (ustekinumab-srlf) is now covered by ...
A frustrating experience, if for no other reason than its pedigree is much more prestigious than the mangy strays of the show ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results